Salesforce Life Sciences Cloud: An Architect’s Guide to Data, Integration, Security, and Agentforce

Life Sciences Cloud is not Sales Cloud with a pharma logo. It changes what your data model owns, how your integrations behave, what “offline” means for a field team, and how much authority you hand to an AI agent. This is the guide for the architect who has to answer for those decisions.

1. What is the Life Sciences Cloud?

Salesforce Life Sciences Cloud is an industry cloud: a layer of purpose-built data objects, business processes, compliance scaffolding, and packaged Agentforce capability built on top of the core Salesforce Platform. It is aimed at pharmaceutical, biotech, medical device (MedTech), consumer health, and animal health companies that need to run clinical, medical affairs, commercial, and patient-service work on one platform instead of working with five.

Why not just use Sales Cloud?

A normal CRM is built around concepts such as accounts, contacts, leads, and opportunities. Life sciences organizations work with more specialized relationships and processes.

For example, a Healthcare Professional (HCP) may have:

• Multiple specialties
• Professional licenses
• Relationships with several healthcare organizations
• Territory assignments
• Consent requirements
• Different engagement rules by country and channel

Clinical operations also have very different requirements from a normal sales process. A clinical study can have multiple sites, investigators, enrolment targets, and regulatory milestones.

You can build these processes on general Salesforce objects, but then the implementation team has to design and maintain much of the industry-specific data model and business logic themselves.

Life Sciences Cloud provides a starting point that is designed around these industry requirements.

Where does it sit in the Salesforce portfolio?

Component	Architectural role
Salesforce Platform	The runtime: objects, Flow, Apex, sharing, security model. Everything else is built on it.
Sales Cloud	General-purpose account/opportunity/pipeline objects. Life Sciences Cloud extends and re-purposes parts of this, it doesn’t replace it.
Service Cloud	Case management, omni-channel routing. Used underneath patient services and medical information contact centres.
Health Cloud	Built for payers and providers—care management, utilization, patient 360 inside a health system or health plan. Different customer, different data ownership model.
Life Sciences Cloud	Built for manufacturers—pharma, biotech, and MedTech engaging HCPs, running trials, and supporting patients on therapy. This is the subject of this article.
Data Cloud	Unification and identity resolution layer across Salesforce and external systems, without necessarily copying everything into Salesforce.
Agentforce	The agent runtime: topics, actions, grounding, and the trust/guardrail layer that sits over Data Cloud and platform data.
MuleSoft	Integration and API management layer connecting Salesforce to EHR/EMR, ERP, CTMS, MDM, and other systems of record.
Experience Cloud	External-facing portals: HCP portals, patient support communities, investigator portals.
Tableau	Analytics and reporting across unified Data Cloud datasets and Salesforce data.

2. Life Sciences Cloud Architecture

Life Sciences Cloud should not be treated as the entire enterprise architecture. A better approach is to treat it as one layer in a larger architecture.

A typical architecture can contain:

1. Channels
2. Experience
3. Agentforce
4. Life Sciences Cloud
5. Data Cloud
6. Integration
7. External systems of record

Security, identity, and analytics can work across all these layers.

Two architectural habits fall out of this picture immediately. First, Life Sciences Cloud objects are not the only place data lives—Data Cloud exists specifically so you don’t have to copy every external record into Salesforce to use it. Second, Agentforce sits above the application layer, not beside it: an agent action should call the same governed automation (Flow, Apex, integration) that a human user would trigger, inheriting the same sharing rules, not a separate privileged path.

3. The Life Sciences data model

The starting design question is not “What objects exist?” but “Who owns this record, and for how long?” Life sciences data can be divided into four distinct types, and a common mistake is to store or model all four types together as if they were the same kind of data.

Category	Examples	Design implication
Master data	HCP identity, HCO identity, Product	One golden record, usually owned by an external MDM—Salesforce holds a synchronized or federated view, not a second master.
Reference data	Specialty codes, territory hierarchies, formulary codes	Slow-changing, often loaded from an external code system; version it, don’t hardcode picklists that regulators may ask you to reproduce historically.
Transactional / engagement data	Visit, Interaction, Sample Drop, Consent Capture	Owned by Salesforce, high volume, needs an archiving strategy from day one.
Clinical data	Study, Study Site, Enrollment Status	Salesforce typically orchestrates and tracks status; the EDC/CTMS remains the system of record for clinical data itself.

Modelling mistakes to avoid

• Combining HCP and Patient into one Account/Contact hierarchy. They have different consent regimes, different retention rules, and usually different owning teams. Keep the graphs separate and link them only through a narrow, purpose-built object when a real business process needs it (e.g., an HCP referring a patient into a support program).
• Treating Affiliation as a lookup field instead of an object. HCPs move between institutions and hold multiple concurrent affiliations, and affiliation history matters for compliance reporting. A single lookup can’t hold that.
• Using territory alignment as security. Alignment is a business attribute (who calls on whom); sharing is an access-control decision. Use both, but don’t assume one implements the other—a former territory owner can still see historical records if sharing rules aren’t re-evaluated on realignment.
• Mixing clinical status fields onto commercial objects. An HCO can be both a commercial customer and a clinical study site. That does not mean every user should see every piece of information about that HCO. Keep clinical and commercial data separately secured.
• Making Salesforce the master for external data. If an MDM system owns HCP identity, do not allow Salesforce to become a second independent master. Use identifiers and synchronization rules to clearly define ownership.

4. HCP and HCO 360 architecture

360 does not mean that all data must be stored in one database. It means users can get a useful, connected view of the information they need.

An architect should decide how each type of data will be handled.

Strategy	When to use it
Stored in Salesforce	Data that Salesforce users edit directly and that drives Salesforce automation—engagement history, consent, and territory assignment.
Stored externally, referenced	Large or sensitive datasets (claims, full prescribing history) where Salesforce only needs a summary or a link-out.
Federated / zero-copy (Data Cloud)	Data you need to reason over or ground an agent with, but don’t want to duplicate or take on the sync burden for—e.g., real-world evidence datasets.
Synchronized	Slower-changing master data (HCP identity, license status) where Salesforce needs local queryability and offline access.
Cached	Expensive-to-fetch, short-lived lookups (e.g., a real-time formulary check)—cache with a TTL rather than storing permanently or calling synchronously every time.

Data Cloud’s identity resolution is what actually makes “360” possible across noisy inputs: an HCP data provider’s spelling of a name, a rep’s manual entry, and an EHR’s NPI-linked record rarely match exactly.

An architect should define:

• Matching rules
• Golden-record ownership
• Conflict handling
• Update frequency
• Country-specific identifiers

A matching strategy that works in one country may not work in another.

Architect’s checklist for HCP/HCO 360

Before designing the 360 solution, answer these questions:

• Who owns the golden HCP record?
• What happens when Salesforce and MDM disagree?
• How often should external data be refreshed?
• Which data must be available offline?
• Which data should remain outside Salesforce?
• Which data can be federated?
• Which users can access each type of data?

5. Life Sciences Cloud Integration Architecture

Life sciences organizations usually have many enterprise systems.

Examples include:

• EHR/EMR
• Clinical trial systems
• ERP
• MDM
• HCP data providers
• Content management systems
• Data warehouses
• Regulatory systems

The integration pattern should depend on the business requirement.

Integration requirement	Recommended architecture	Why
HCP identity sync from MDM	Batch/CDC via MuleSoft into Salesforce, or Data Cloud federation if Salesforce doesn’t need local edit	MDM is a system of record; near-real-time isn’t usually needed, and full duplication adds sync burden.
Clinical trial status (CTMS/EDC)	Scheduled batch or event-driven status updates via Platform Events	Status changes are usually milestone-driven.
EHR/EMR data for patient programs	Synchronous REST call at point of need, narrowly scoped	PHI-heavy, high-sensitivity data—Retrieve only what is needed at the point of use.
Sample/inventory transactions to ERP (SAP)	Asynchronous, guaranteed delivery via MuleSoft	Financial/compliance data cannot be silently dropped; it needs durability, not raw speed.
HCP prescribing/market data feed	Bulk API batch load into Data Cloud, not core Salesforce objects.	High volume, analytical use—doesn’t need to live in transactional Salesforce storage.
Content/medical information documents (CLM)	API-based retrieval, content stored in a CMS, metadata only in Salesforce	Large binary content bloats Salesforce storage costs for no architectural benefit.
Regulatory/adverse-event reporting	Synchronous, transactional API call with confirmed receipt, plus audit log	Regulatory obligations often require confirmed, timestamped submission—a fire-and-forget event is not sufficient.
Real-time formulary or benefits check	Synchronous external service call, cached briefly	Needs current data at decision time; full replication would always be stale.

6. Security and compliance architecture

Salesforce’s standard security model—object, field, and record-level access; permission sets and permission set groups; sharing sets and sharing rules; encryption; and event monitoring—is the mechanism.

Compliance is the outcome, and the two are not the same thing. A perfectly configured permission model does not make an implementation GxP (good practice standards—GCP, GMP, GVP)—compliant on its own; that also requires validation documentation, change control, training records, and organizational processes. The architect should design the technical controls and work with security, legal, quality, and compliance teams to determine the complete compliance requirements.

Concept	What it constrains	Typical life sciences use
Object/field-level security	What a profile or permission set can see or edit at all	Hide clinical trial financial fields from commercial field reps.
Record-level access / sharing	Which specific records a user can see	A rep sees only HCPs in their aligned territory; a medical affairs user sees HCPs regardless of territory but not commercial engagement detail.
Permission Set Groups	Composable, role-based bundles of access	“Field Rep – Oncology,” “Medical Science Liaison,” and “Patient Services Agent” as distinct, auditable bundles.
Encryption (Shield Platform Encryption)	Data at rest, including in backups and some derived indexes	Fields holding patient-identifiable or sensitive HCP data.
Event Monitoring	Who accessed what, when — including API and login activity	Detecting bulk export of HCP or patient data outside normal patterns.
Data masking	De-identifying data in non-production environments	Sandboxes used for development/testing must not contain real patient data.
Consent management	Whether a given channel/purpose is permitted for a given HCP or patient	Blocking email outreach to an HCP who withdrew marketing consent in one country but not another.
Integration-user least privilege	What an integration user account can do	An MDM sync user should have write access to specific fields, not the system administrator.

Read Guide: Salesforce Outbound Message vs Platform Event: A Complete Architect’s Guide

Regulatory considerations

Architects may need to consider regulations and standards such as

• GxP (good practice standards—GCP, GMP, GVP)
• GDPR
• HIPAA
• 21 CFR Part 11

The exact requirements depend on the organization, country, process, and data involved. Do not assume that every life sciences implementation has the same regulatory requirements.

The architect should identify where each regulation may apply and work with the appropriate legal and quality teams.

7. Mobile and offline architecture

Field representatives work for hours without connectivity—inside hospitals, in rural territories, and on flights. This makes offline architecture important. Offline Salesforce behavior is not simply the desktop Salesforce experience with some records cached on a device. The timing of server-side processing changes when the device is offline.

Practical consequences architects must design for:

• Validation rules deferred, not skipped. A rep can save a visit that would fail a validation rule requiring a linked consent record if that consent was itself created offline in the same session and hasn’t synced yet. Design validation to tolerate same-session ordering, or defer hard validation to post-sync.
• Automation timing shifts. A platform event meant to trigger a same-day follow-up email will instead fire hours later, when the device reconnects. If the business process assumes near-real-time, that assumption breaks in the field.
• Conflict handling needs an explicit policy—last-write-wins is the default in many mobile sync frameworks, but for consent or compliance-sensitive fields, silently overwriting a server-side change may be the wrong answer.
• Local data footprint must be limited deliberately: syncing an entire territory’s HCP and engagement history to every device multiplies data loss and data residency exposure if a device is lost.
• Security still applies offline. Local storage should be encrypted at rest on the device, and a lost/stolen device policy (remote wipe, short session timeout) is part of the architecture, not an afterthought for IT.

8. Agentforce architecture for Life Sciences

Agentforce doesn’t sit “beside” Life Sciences Cloud; it sits on top of it, invoking the same governed actions a human user would. An agent is defined by topics (the areas of work it’s scoped to), actions (specific flows, Apex, or API calls it’s permitted to invoke), grounding against Data 360, and a Trust Layer that mediates what the underlying model sees and returns.

Use case	Business problem	Data required	Human oversight
HCP briefing	The rep needs a fast, accurate pre-call summary.	Engagement history, consent status, recent content sent	The rep reviews before the call; the agent doesn’t message the HCP directly.
Visit preparation	Compiling relevant talking points and open items	Territory data, product data, prior visit notes	Suggested, not sent, without rep confirmation
Medical information request	Answering an HCP’s clinical question accurately	Approved medical content only—never open web grounding for clinical claims	Escalation to a medical information specialist for anything outside approved content
Clinical trial site selection	Ranking candidate sites by enrollment likelihood	Historical enrollment data, site capability, investigator history	Study team makes the final selection; the agent narrows the list
Patient support	Answering program eligibility and status questions	Patient program enrollment data, strictly scoped, no clinical diagnosis data	Human agent handoff for anything ambiguous or emotionally sensitive
Benefits verification	Checking coverage status faster than a manual call	Payer/benefits data via a governed integration, not stored permanently	The result was shown to a human agent, not auto-communicated to the patient.
Field rep assistance	Logging a visit from a voice note	The rep’s own dictated notes	Rep reviews and approves the generated record before it saves
Account summarization	Rolling up an HCO’s engagement across many reps	Engagement, affiliation, territory data	Read-only output—summarization actions shouldn’t also carry write authority

9. Agentforce security

The core anti-pattern to design against is an agent that can see or do more than the human user it’s acting on behalf of. Concretely:

• Run agent actions in user context. An action invoked by an agent should be subject to the same field-level security and sharing rules as if the user had clicked the button themselves. A service account with elevated privileges powering the agent defeats the entire access model.
• Ground narrowly. Grounding an agent against “all of Data 360” because it’s convenient means every topic can potentially surface every dataset. Scope grounding sources per topic—a patient-support topic should not have HCP prescribing data in its retrieval scope, and vice versa.
• Treat prompt injection as a live threat, not a hypothetical. Content ingested from external sources (an inbound email, a scanned document, or a web page) can contain instructions aimed at the model, not the user. Anything an agent retrieves as context should be treated as untrusted data, not as instructions.
• Separate suggest from act. Actions with external or irreversible consequence (sending a communication to an HCP, submitting a regulatory record) should require human confirmation. Actions that are read-only or fully reversible are reasonable to automate.
• Log everything an agent does, at the same fidelity as a human user’s actions—which action ran, what data it touched, and what output it returned—so an audit can reconstruct exactly what happened.
• Don’t let an agent’s summarization become a data leak. A summary that quietly aggregates across a boundary a human user couldn’t cross on their own (e.g., combining clinical and commercial data a single profile shouldn’t see together) is a security failure even if no single underlying query was unauthorized.

Read Guide: Basics of Securing Salesforce Application

10. Scale and large data volumes

Life Sciences generates volume in three places at once: engagement history (every visit, every content share, across every rep, every day), event data (Platform Events from integrations), and external datasets (prescribing data, real-world evidence) that are tempting to import wholesale. The architectural discipline is deciding what doesn’t go into core Salesforce storage.

• Route high-volume, low-edit analytical data (market/prescribing feeds) into Data 360 rather than custom objects—it’s built for this volume and avoids Salesforce storage and query-performance costs.
• Archive engagement history on a defined retention schedule; regulated retention requirements (which can require keeping data, not just deleting it) should drive the archive destination, not just deletion.
• Design integration volume against API limits deliberately—bulk API for large scheduled loads, not high-frequency REST calls for the same data.
• Use asynchronous processing (Queueable Apex, Platform Events) for anything triggered by a large data load, rather than synchronous transaction-time processing that will hit governor limits under volume.
• Don’t assume “we might need it later” is sufficient justification to store an external dataset permanently in Salesforce; federation exists precisely so you don’t have to make that bet.

Read Guide: How to Effectively Manage Large Data Volumes in Salesforce?

11. Architecture decision framework

Requirement	Recommended pattern	Avoid when	Architect consideration
Salesforce vs. external system	Salesforce for anything a user edits or that drives the Salesforce process	The data is high-volume, analytical, or already has an authoritative system.	Ownership, not convenience, should decide where data lives
Real-time vs. batch	Real-time only when a user is waiting on the answer	The consuming process tolerates delay — batch is cheaper and simpler to operate	Real-time integrations need monitoring and failure handling batch doesn’t
API vs. event	API for request/response; events for “something happened, react if you care”	The outcome must be confirmed (use API, not fire-and-forget events)	Events decouple systems but hide delivery guarantees unless designed explicitly
Replication vs. federation	Federation (Data 360) when Salesforce only needs to reason over data, not edit it	Offline access or heavy local querying is required — replicate a scoped subset instead	Every replicated field is a future sync-conflict and drift risk
Flow vs. Apex	Flow for business-rule logic that changes often and is owned by admins	Complex logic, bulk processing, or tight performance requirements — use Apex	Flow proliferation without governance becomes as hard to maintain as spaghetti code
Salesforce automation vs. MuleSoft	MuleSoft for cross-system orchestration and protocol translation	The logic is purely internal to Salesforce data — keep it in Flow/Apex	Don’t route purely internal automation through an external integration layer “for consistency”
Salesforce storage vs. Data 360	Data 360 for unification, identity resolution, and analytical volume	Records need transactional edit and sharing-rule enforcement — use Salesforce objects	Data 360 is not a replacement for the object model; it’s a companion to it
Agentforce vs. deterministic automation	Agentforce for judgment-requiring, language-heavy tasks (summarizing, drafting, retrieving)	The task has one correct answer and full input data — a Flow is more auditable and cheaper	Don’t reach for an agent because it’s available; reach for it because the task genuinely needs reasoning over unstructured input
Synchronous vs. asynchronous integration	Synchronous for user-blocking decisions; asynchronous for everything else	Downstream systems have unpredictable latency — don’t make a user wait on a system you don’t control	Timeout and retry behavior needs to be designed explicitly either way

Read Guide: Understanding the Salesforce Well-Architected Framework to Enhance Business Outcome

12. 10 Life Sciences Cloud architecture anti-patterns

1. Treating Life Sciences Cloud as a generic Sales Cloud

Salesforce teams often have deep experience with Sales Cloud, so it can be tempting to start a Life Sciences Cloud implementation with the same objects, processes, and design patterns used in a traditional sales implementation.

This approach misses an important point: Life Sciences Cloud is designed around the specific needs of the life sciences industry. Healthcare providers, patients, clinical information, medical activities, products, and regulatory requirements introduce business concepts that are different from a typical sales process.

2. Over-Customizing Industry-Specific Functionality

Teams often over-customize Life Sciences Cloud because every organization believes its processes are unique. While some customization is necessary, replacing or heavily modifying industry-specific capabilities can create unnecessary technical debt.

The result is a solution that becomes harder to maintain, more expensive to upgrade, and increasingly dependent on custom code and automation. Heavy customization should be treated as a signal to revisit the requirement before building it.

3. Storing Every External Dataset in Salesforce

Teams sometimes copy every available external dataset into Salesforce because they believe data is safer and more useful once it is inside the platform. However, not every piece of data needs to be physically stored in Salesforce.

Unnecessary data replication increases storage consumption, can affect query and processing performance, and creates another copy of the data that can become inconsistent with the source system.

4. Ignoring Offline Behavior in Process Design

Life Sciences Cloud users such as field representatives may work in environments where network connectivity is limited or unavailable, so designing processes only for an online experience is a common mistake. Teams may build validation rules, automation, and user flows without considering what happens when data is created or changed offline and synchronized later.

This can result in unexpected validation failures, automation behaviour, synchronization conflicts, or a poor user experience for field users.

5. Building Point-to-Point Integrations Everywhere

Point-to-point integration can appear to be the fastest way to connect Salesforce with another system, especially when the project starts with only one or two integrations. The problem appears as more systems are added: each new connection creates additional dependencies, transformation logic, security requirements, and monitoring points.

6. Giving Integration Users Excessive Permissions

Integration users are sometimes given broad permissions, such as System Administrator access, simply because it is faster than designing the correct security model.

This creates a significant security risk because a compromised integration credential could potentially access or modify much more data than the integration actually requires.

7. Allowing AI Agents Unrestricted Data Access

Teams may give AI agents broad access to Salesforce data because they assume that more data will make the agent more capable and produce better answers. However, unrestricted grounding can allow an agent to surface information across business or security boundaries that the requesting user should not normally access.

This becomes especially important in Life Sciences environments where commercial, medical, clinical, and other sensitive information may coexist. A better approach is to scope agent grounding to the specific topics and data the agent needs and ensure that every action runs within the requesting user’s appropriate security and permission context.

8. Ignoring Master-Data Ownership

Master-data ownership is often overlooked because allowing Salesforce users to directly update records such as healthcare professional or healthcare organization information appears simpler. The problem occurs when another system, such as an MDM platform, is also responsible for the same data.

Without clear ownership, Salesforce and the external master-data system can contain conflicting values, creating duplicate records, synchronization issues, and uncertainty about which value is authoritative.

9. Mixing Clinical and Commercial Data Without Access Design

Keeping all information related to a healthcare organization or healthcare professional in one broadly accessible record may seem convenient, but it can create serious security and compliance concerns. Clinical and commercial information often have different users, purposes, and access requirements.

ithout a clear security model, commercial users could potentially see clinical information, or users working with clinical processes could gain access to commercial information that they do not need.

10. Designing for One Country When Global Rollout Is Expected

A Salesforce implementation often starts with one country, and teams naturally focus on that market’s requirements. The problem occurs when country-specific assumptions become embedded in the data model, consent processes, identifiers, integrations, and business rules, making expansion into additional markets difficult and expensive.

For example, healthcare identifiers, consent requirements, privacy rules, and regulatory processes can vary significantly between countries. A better approach is to design the core model so that country-specific requirements can be configured through parameters rather than hard-coded into the solution.

13. Frequently Asked Questions

1. What is Salesforce Life Sciences Cloud?

Salesforce Life Sciences Cloud is an industry-specific Salesforce solution designed for pharmaceutical, biotech, MedTech, consumer health, and animal health organizations. It supports areas such as HCP engagement, clinical operations, medical affairs, and patient services.

2. How is Salesforce Life Sciences Cloud different from Health Cloud?

Health Cloud generally focuses on healthcare providers, payers, and care-management use cases, while Life Sciences Cloud focuses on manufacturers such as pharmaceutical, biotech, and MedTech companies. Their data models and data-ownership requirements can therefore be different.

3. What should a Salesforce Architect consider when designing Life Sciences Cloud?

An architect should define data ownership, system-of-record boundaries, integration patterns, security, consent, offline behavior, scalability, compliance requirements, and AI governance before designing the solution.

4. Should all Life Sciences data be stored in Salesforce?

No. Salesforce should store data that users need to manage or that Salesforce processes need to use. High-volume, analytical, sensitive, or externally owned data may be better kept in an external system or accessed through Data 360 and appropriate integration patterns.

5. How should HCP and HCO data be designed in Life Sciences Cloud?

HCP and HCO data should have clear ownership and identity rules. Relationships between HCPs and HCOs should be explicitly modeled because an HCP can have multiple affiliations that can change over time.

6. When should an architect use Data 360 with Life Sciences Cloud?

Data 360 can be used when an organization needs to unify Salesforce and external data, resolve identities, or work with data that does not need to be stored as transactional Salesforce records. The decision should be based on data ownership, access, volume, and business requirements.

7. What integration patterns are commonly used with Salesforce Life Sciences Cloud?

Common patterns include synchronous APIs for immediate responses, Platform Events or Change Data Capture for event-driven processing, and bulk or batch processing for large data volumes. MuleSoft can provide an integration and API-management layer for enterprise integrations.

8. How does offline functionality affect Life Sciences Cloud architecture?

Offline usage changes when server-side processing occurs. Data captured while offline is synchronized when connectivity returns, so architects must consider delayed validation, automation, event processing, conflict handling, local data storage, and device security.

9. How should Agentforce be secured in a Life Sciences Cloud implementation?

Agentforce should have clearly defined topics, actions, data sources, and grounding boundaries. Agents should not receive broader access than required, and sensitive or irreversible actions should have appropriate human oversight and auditing.

10. What are the most common Life Sciences Cloud architecture anti-patterns?

Common anti-patterns include treating Life Sciences Cloud as generic Sales Cloud, over-customizing industry functionality, storing every external dataset in Salesforce, ignoring offline behavior, creating point-to-point integrations, giving integration users excessive permissions, and allowing AI agents unrestricted access to data.

11. How should Salesforce Life Sciences Cloud integrate with clinical trial systems?

Salesforce can track study and site relationships and relevant status information, while the clinical trial system such as an EDC or CTMS can remain the system of record for detailed clinical data. The integration pattern should be selected based on the required latency, volume, and business process.

12. Is Salesforce Life Sciences Cloud suitable for large pharmaceutical organizations?

Yes, but the solution should be designed as an enterprise architecture rather than putting all data and processing into Salesforce. System-of-record ownership, integration architecture, Data 360, security, data volume, offline requirements, and global regulatory considerations should be addressed early.

Summary

Salesforce Life Sciences Cloud brings industry-specific capabilities to Salesforce for pharmaceutical, biotech, MedTech, consumer health, and animal health organizations. This architect-focused guide explains how to design Life Sciences Cloud solutions across data modeling, HCP/HCO 360, integration, security and compliance, mobile and offline processing, Data 360, Agentforce, scalability, and architecture governance. It also covers common architecture anti-patterns, a real-world reference architecture, an implementation roadmap, and practical interview questions to help architects make better design decisions.

Related Posts

1. Salesforce Sharing Model Anti-Patterns: Common Mistakes That Hurt Security and Scalability
2. 10 Salesforce Large Data Volume Anti-Patterns That Kill Performance
3. Data Architecture Anti-Patterns – Lookup Relationship Anti-Patterns
4. Data Architecture Anti-Patterns Every Architect Should Avoid
5. Dependency Inversion Principle (DIP) in Salesforce Apex — A Complete Guide
6. Interface Segregation Principle (ISP) in Salesforce Apex — A Complete Guide
7. Mastering Liskov Substitution Principle in Apex
8. Open/Closed Principle (OCP) in Salesforce Apex — A Complete Guide
9. Single Responsibility Principle (SRP) in Salesforce Apex — A Complete Guide
10. The Art of Naming (Clean Code for Salesforce Developers)
11. Salesforce Outbound Message vs Platform Event: A Complete Architect’s Guide
12. How to Elevate Your Career to Salesforce Architect